storing reconstituted retatrutide (RETA) – Research Peptide Buy Retatrutide (60 mg) |

Stacking MOTS-C with Retatrutide is relatively straightforward, but these common pitfalls can derail an otherwise well-designed protocol

Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials

& Gossop, M

We focus on 90-day goals, not weekly pressure

Integrating retatrutide with complementary endocrine tools Because most endocrine and metabolic studies are designed around panels of interventions rather than single-agent experiments, the REDF program will also explore how Retatrutide can be positioned alongside other commonly used research tools such as growth-hormone secretagogues and appetite-modulating compounds